Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population ☆
Titel:
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population ☆
Auteur:
Seligmann, J.F. Morton, D. Elliott, F. Handley, K. Gray, R. Seymour, M. Glimelius, B. Magill, L. Williams, C.J.M. Quirke, P. Bottomley, D. Wood, H.M. Murakami, K. Beggs, A.D. West, N.P.